Newsletter July 2023 No.216
Top News
On May 25, 2023, the "JPMA Press Conference" was held in front of Bellesalle Iidabashi Station (Chiyoda-ku, Tokyo). At the press conference, JPMA President Hiroaki Ueno, who was newly elected at the 268th JPMA Assembly held on the same day, delivered a statement of policy and discussed the challenging environment facing the industry and JPMA's future initiatives under the title of "Toward a Nation Driven by Innovation". The press conference was held in a hybrid format of on-site and online, with 29 members of the press from 22 companies in attendance and a lively Q&A session, indicating a high level of interest in the future direction of the pharmaceutical industry. The following is a summary of Chairman Ueno's presentation and the Q&A session.
Topics
- The 12th Asian Pharmaceutical Association Collaboration Conference (APAC) - Bringing Innovative Medicines to the People of Asia Quickly
- Joint Symposium with the Joint Meeting of the Japanese Society of Infectious Diseases/Japanese Society of Chemotherapy" was held.
Bringing Antimicrobial Agents from Japan to the World Again! Building a Drug Discovery Ecosystem through Industry-Academia-Government Collaboration - JPMA Media Forum: What to do about Vaccines? -What can we do now for the future?
- JPMA Media Forum on Health and Economy "The Future of Health Economics Research in Japan's Aging Society, a Global Focus
- Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for FY2023
Policy Research Institute
Trends in medical record integration as seen in the case of COVID-19
From JPMA
On assuming the office of Chairman - Aiming for a country where innovation is dynamic